Determination of procarbazine in human plasma by liquid chromatography with electrospray ionization mass spectrometry

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 799, Issue 2, 2004, Pages 281-291

  He, X ^a   Batchelor, T T ^a   Grossman, S ^b   Supko, J G ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Procarbazine

Indexed keywords

BRAIN; CHEMOTHERAPY; IONIZATION; MASS SPECTROMETRY; ORGANIC COMPOUNDS; PATIENT TREATMENT; PHARMACOKINETICS; PROTEINS; TUMORS;

HUMAN PLASMA;

HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

3 DIMETHYLAMINO 2 METHYLPROPIOPHENONE; AMMONIUM ACETATE; ANTINEOPLASTIC AGENT; PROCARBAZINE; PROPIOPHENONE DERIVATIVE; PROTEIN; TERT BUTYL METHYL ETHER; TRICHLOROACETIC ACID; UNCLASSIFIED DRUG;

ACCURACY; ANALYTIC METHOD; ARTICLE; BLOOD SAMPLING; BRAIN CANCER; CALIBRATION; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG STABILITY; ELECTROSPRAY MASS SPECTROMETRY; HUMAN; MASS SPECTROMETER; PH; PRECIPITATION; PRIORITY JOURNAL; QUALITY CONTROL; REPRODUCIBILITY; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SUPERNATANT;

EID: 0344665700     PISSN: 15700232     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchromb.2003.10.061     Document Type: Article

References (26)

1. H.S. Friedman, S.D. Averbuch, J. Kurtzberg, in: B.A. Chabner, D.L. Longo (Eds.), Cancer Chemotherapy and Biotherapy, 3rd ed., Lippincott Williams and Wilkins, Philadelphia, 2001, p. 415.
2. Oliverio V.T., Denham C., DeVita V.T., Kelly M.G. Cancer Chemother. Rep. 42:1964;1.
3. Gorsen R.M., Weiss A.J., Manthei R.W. J. Chromatogr. 221:1980;309.
4. Shiba D.A., Weinkam R.J. J. Chromatogr. 229:1982;397.
5. Zeller P., Gutmann H., Hegedus B., Kaiser A., Langemann A., Muller M. Experientia. 19:1963;129.
6. Baggiolini M., Dewald B., Aebi H. Biochem. Pharmacol. 18:1969;2187.
7. Weinkam R.J., Shiba D.A. Life Sci. 22:1978;937.
8. Dunn D.L., Lubet R.A., Prough R.A. Cancer Res. 39:1979;4555.
9. Kuttab S.H., Tanglertpaibul S., Vouros P. Biomed. Mass Spectrom. 9:1982;78.
10. Swaffar D.S., Pomerantz S.C., Harker W.G., Yost G.S. Oncol. Res. 4:1992;49.
11. Erikson J.M., Tweedie D.J., Ducore J.M., Prough R.A. Cancer Res. 49:1989;127.
12. Swaffar D.S., Horstman M.G., Jaw J.-Y., Thrall B.D., Meadows G.G., Harker W.G., Yost G.S. Cancer Res. 49:1989;2442.
13. Newell D., Gerscher A., Harland S., Ross D., Rutty C. Cancer Chemother. Pharmacol. 19:1987;91.
14. Ciordia R., Supko J., Gatineau M., Batchelor T. Curr. Oncol. Rep. 2:2000;445.
15. Shiba D.A., Weinkam R.J. Cancer Chemother. Pharmacol. 11:1983;124.
16. K.A. Connors, G.L. Amidon, V.J. Stella, Chemical Stability of Pharmaceuticals, 2nd ed., Wiley, New York, 1986, p. 8.
17. J. Gabrielsson, D. Weiner, Pharmacokinetic/Pharmacodynamic Data Analysis: Concepts and Applications, Swedish Pharmaceutical Press, Stockholm, 1994.
18. Andrews J.E., Ebron-McCoy M., Copeland F., Glennon J.J. Toxicol. Appl. Pharm. 126:1994;260.
19. Rucki R.J., Ross A., Moros S.A. J. Chromatogr. 190:1980;359.
20. Swaffar D.S., Harker W.G., Pomerantz S.C., Lim H.-K., Yost G.S. Drug Metab. Dispos. 20:1992;632.
21. Berneis K., Kofler M., Bollag W., Zeller P., Kaiser A., Langemann A. Helv. Chim. Acta. 46:1963;2157.
22. Blanchard J. J. Chromatogr. Biomed. Appl. 226:1981;455.
23. Buhrman D., Price P., Rudewicz P. J. Am. Mass Spectrom. 7:1996;1099.
24. Matuszewski B.K., Constanzer M.L., Chavez-Eng C.M. Anal. Chem. 70:1998;882.
25. Prough R.A., Brown M.I., Dannan G.A., Guengerich F.P. Cancer Res. 44:1984;543.
26. Lehmann D.F., Hurteau T.E., Newman N., Coyle T.E. Clin. Pharmacol. Ther. 62:1997;225.